← Leaderboards
Ronald K Liem
Columbia University Health Sciences
$20,204,073
Attributed
$21,910,638
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,910,638 · 9
By mechanism
T32$14,406,586 · 3
R01$6,480,358 · 4
RC1$823,694 · 1
R21$200,000 · 1
Top collaborators
- Rebecca Anne Haeusler3 shared
- Donna L Farber1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Tilla S Worgall$497,232
- Catherine A Marquer$754,729
- Gilbert Di Paolo$6,970,861
- Bethany Leslie Johnson-Kerner$42,232
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTrainingNeuronsGene ExpressionProtein Structure FunctionNeurofilamentLaboratory MouseAxonMutationNeurogenesisGene MutationDefectBaseGenetically Modified AnimalsCellsLifeTissue /Cell CultureMutantIntermolecular InteractionProteinsNeurofilament ProteinsGenesNerve DegenerationAffect
Grant awards (52)
Training in Cellular, Molecular and Biomedical Studies (CMBS)$852,721
T32 · FY2025 · GM
Training in Cellular, Molecular and Biomedical Studies (CMBS)$878,975
T32 · FY2024 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies (CMBS)$848,856
T32 · FY2023 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies (CMBS)$832,579
T32 · FY2022 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$546,154
T32 · FY2021 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$482,056
T32 · FY2020 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$476,613
T32 · FY2019 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$565,559
T32 · FY2018 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$466,115
T32 · FY2017 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$454,576
T32 · FY2016 · GM · contact PI
Role of phosphoinositides in neuronal membrane traffic and neurodegeneration$349,401
R01 · FY2016 · NS · contact PI
Training in Cellular, Molecular and Biomedical Studies$456,136
T32 · FY2015 · GM · contact PI
Role of phosphoinositides in neuronal membrane traffic and neurodegeneration$348,822
R01 · FY2015 · NS · contact PI
Deciphering the metabolism of LBPA and its function in the endolysosomal system$200,000
R21 · FY2015 · NS · contact PI
Training in Cellular, Molecular and Biomedical Studies$451,341
T32 · FY2014 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$446,546
T32 · FY2013 · GM · contact PI
Training in Cellular, Molecular and Biomedical Studies$446,546
T32 · FY2012 · GM · contact PI
Training in Cellular, Molecular and Biophysical Studies$441,684
T32 · FY2011 · GM · contact PI
Training in Cellular, Molecular and Biophysical Studies$437,344
T32 · FY2010 · GM · contact PI
Identification of Compounds to treat Charcot-Marie-Tooth type 2E neuropathy$409,260
RC1 · FY2010 · NS · contact PI
Training in Cellular, Molecular and Biophysical Studies$435,141
T32 · FY2009 · GM · contact PI
Identification of Compounds to treat Charcot-Marie-Tooth type 2E neuropathy$414,434
RC1 · FY2009 · NS · contact PI
Training in Cellular, Molecular and Biophysical Studies$432,938
T32 · FY2008 · GM · contact PI
Training in Cellular, Molecular and Biophysical Studies$432,938
T32 · FY2007 · GM · contact PI
Biochemistry of the Neuronal Cytoskeleton$368,191
R01 · FY2007 · NS · contact PI
Mechanism of neurodegeneration in dystonia musculorum$313,802
R01 · FY2007 · NS · contact PI
Training in Cellular, Molecular and Biophysical Studies$444,861
T32 · FY2006 · GM · contact PI
Biochemistry of the Neuronal Cytoskeleton$379,188
R01 · FY2006 · NS · contact PI
Mechanism of neurodegeneration in dystonia musculorum$371,129
R01 · FY2006 · NS · contact PI
Training in Cellular, Molecular and Biophysical Studies$451,068
T32 · FY2005 · GM
Biochemistry of the Neuronal Cytoskeleton$388,313
R01 · FY2005 · NS
Mechanism of neurodegeneration in dystonia musculorum$330,171
R01 · FY2005 · NS
Mechanism of neurodegeneration in dystonia musculorum$47,898
R01 · FY2005 · NS
Training in Cellular, Molecular and Biophysical Studies$451,068
T32 · FY2004 · GM
Biochemistry of the Neuronal Cytoskeleton$388,313
R01 · FY2004 · NS
Mechanism of neurodegeneration in dystonia musculorum$329,860
R01 · FY2004 · NS
A Cytoskeletal Linker Protein Involved in Axon Outgrowth$325,710
R01 · FY2004 · NS
Training in Cellular, Molecular and Biophysical Studies$442,384
T32 · FY2003 · GM
Biochemistry of the Neuronal Cytoskeleton$388,313
R01 · FY2003 · NS
A Cytoskeletal Linker Protein Involved in Axon Outgrowth$325,238
R01 · FY2003 · NS
CELLULAR AND NEUROBIOLOGICAL ASPECTS OF AGING$95,820
T32 · FY2003 · AG
Training in Cellular, Molecular and Biophysical Studies$422,815
T32 · FY2002 · GM
BIOCHEMISTRY OF THE NEURONAL CYTOSKELTON$403,662
R01 · FY2002 · NS
CELLULAR AND NEUROBIOLOGICAL ASPECTS OF AGING$363,504
T32 · FY2002 · AG
A Cytoskeletal Linker Protein Involved in Axon Outgrowth$324,783
R01 · FY2002 · NS
BIOCHEMISTRY OF THE NEURONAL CYTOSKELTON$392,324
R01 · FY2001 · NS
TRAINING IN CELLULAR, MOLECULAR AND BIOPHYSICAL STUDIES$351,279
T32 · FY2001 · GM
CELLULAR AND NEUROBIOLOGICAL ASPECTS OF AGING$337,619
T32 · FY2001 · AG
Cytoskeletal Linker Protein Involved in Axon Outgrowth$324,343
R01 · FY2001 · NS
BIOCHEMISTRY OF THE NEURONAL CYTOSKELTON$380,897
R01 · FY2000 · NS
TRAINING IN CELLULAR, MOLECULAR AND BIOPHYSICAL STUDIES$342,048
T32 · FY2000 · GM
CELLULAR AND NEUROBIOLOGICAL ASPECTS OF AGING$319,302
T32 · FY2000 · AG